| Product Code: ETC416421 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Hydromorphone is a potent opioid used for pain management in severe medical conditions. In Thailand, the hydromorphone market reflects the broader trends in healthcare and the management of chronic pain. The market is influenced by regulatory measures to control opioid misuse while ensuring access for patients who genuinely require it. Pharmaceutical companies operating in Thailand are focusing on developing extended-release formulations and alternative pain management options. Balancing the need for pain relief with the potential for misuse is a key challenge in this market.
The Thailand hydromorphone market is witnessing growth driven by various factors. Firstly, there is a rising prevalence of chronic pain conditions in the country, which has increased the demand for potent pain-relief medications like hydromorphone. Additionally, the aging population is contributing to the higher incidence of pain-related disorders. Furthermore, the healthcare system`s focus on improving pain management and the availability of advanced pharmaceutical formulations are propelling market expansion. Importantly, increased awareness of pain management among healthcare professionals and patients is also boosting hydromorphone usage.
The Thailand hydromorphone market faces challenges primarily associated with opioid control and healthcare practices. Hydromorphone is a potent opioid, and its use is tightly regulated due to the risk of misuse and addiction. Striking a balance between providing pain relief for patients and preventing misuse poses a significant challenge. Healthcare professionals must undergo specialized training in opioid management, and regulatory agencies must enforce stringent controls. Public education on responsible opioid use is also crucial to address these challenges.
The pandemic had implications for the pharmaceutical industry, impacting the hydromorphone market in Thailand. Increased demand for opioids for pain management in COVID-19 patients and disruptions in the pharmaceutical supply chain affected the availability of hydromorphone. Regulatory changes aimed at ensuring the appropriate use of opioids also influenced market dynamics. This market faced both increased demand and operational challenges during the pandemic.
In the pharmaceutical industry in Thailand, the hydromorphone market was likely dominated by well-established pharmaceutical companies such as Thai Opioids, which produced and distributed hydromorphone-based medications.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Hydromorphone Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Hydromorphone Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Hydromorphone Market - Industry Life Cycle |
3.4 Thailand Hydromorphone Market - Porter's Five Forces |
3.5 Thailand Hydromorphone Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Hydromorphone Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Thailand Hydromorphone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Thailand |
4.2.2 Growing awareness about the effectiveness of hydromorphone in pain management |
4.2.3 Rise in healthcare expenditure and improved access to healthcare facilities in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory policies and restrictions on opioid prescriptions |
4.3.2 High risk of misuse, abuse, and addiction associated with hydromorphone |
4.3.3 Competition from alternative pain management therapies and medications |
5 Thailand Hydromorphone Market Trends |
6 Thailand Hydromorphone Market, By Types |
6.1 Thailand Hydromorphone Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Hydromorphone Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Thailand Hydromorphone Market Revenues & Volume, By Oral, 2021-2031F |
6.1.4 Thailand Hydromorphone Market Revenues & Volume, By Injection, 2021-2031F |
6.2 Thailand Hydromorphone Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Hydromorphone Market Revenues & Volume, By Hospital, 2021-2031F |
6.2.3 Thailand Hydromorphone Market Revenues & Volume, By Drug Store, 2021-2031F |
7 Thailand Hydromorphone Market Import-Export Trade Statistics |
7.1 Thailand Hydromorphone Market Export to Major Countries |
7.2 Thailand Hydromorphone Market Imports from Major Countries |
8 Thailand Hydromorphone Market Key Performance Indicators |
8.1 Number of prescriptions for hydromorphone by healthcare providers |
8.2 Patient satisfaction and pain relief levels reported with hydromorphone use |
8.3 Adoption rate of hydromorphone in hospitals and clinics for pain management |
8.4 Number of healthcare professionals trained in prescribing and monitoring hydromorphone use |
8.5 Rate of adverse events and misuse cases associated with hydromorphone |
9 Thailand Hydromorphone Market - Opportunity Assessment |
9.1 Thailand Hydromorphone Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Hydromorphone Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Thailand Hydromorphone Market - Competitive Landscape |
10.1 Thailand Hydromorphone Market Revenue Share, By Companies, 2024 |
10.2 Thailand Hydromorphone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |